Purpose. Members of the ST127 uropathogenic E. coli (UPEC) clone have a high virulence potential and are also highly virulent in insect infection models. However, strains of this lineage are reported in relatively low numbers in many studies. ST127 strains are also usually widely susceptible to antibiotics and, consequently, their true prevalence may be underrecognized as they will be eradicated during empirical therapy. A genuine concern is the possibility that members of this highly virulent lineage will acquire resistance, leading to a more serious threat. The aim of this study was to design and validate a PCR assay specific to ST127.
INTRODUCTION
Escherichia coli ST127 is a recently emerged clone [1] responsible for a significant proportion of extra-intestinal infections primarily of the urinary tract [1] , but it has also been implicated in bloodstream infections (BSI) [2, 3] and necrotizing enterocolitis in pre-term infants [4] . Members of the ST127 clone possess the common uropathogenic O6 serotype [5] and display an increased lethality in comparison to the more common UPEC ST lineages (ST73, ST131, ST95) with an in vivo model of infection (Galleria mellonella) [6] . Additionally, ST127 strains consistently exhibit higher scores in virulence factor PCR-based assays compared to representatives of some of the more frequently encountered UPEC STs [1, [6] [7] [8] [9] . Members of the ST127 clone are often reported in relatively low, but significant, proportions in prevalence studies [1, 10, 11] .
In general and going against the trend seen in other leading lineages, ST127 isolates are fully susceptible to antibiotics commonly used for the empirical treatment of urinary tract infection (UTI) [7, [11] [12] [13] . They are, therefore, likely to be relatively under-represented in most published prevalence surveys, given that such studies are frequently based on UPEC isolates collected from clinical laboratories from individuals who have failed antimicrobial therapy; it could be predicted that empirical therapy will usually result in elimination of ST127 isolates. Studies from Europe, Canada, Saudi Arabia and Japan [1, 3, 7, 10, 14] report ST127 at low, but often significant, levels. A recent study by Yamaji and colleagues [15] focused on community-acquired UTI (CA-UTI) within a Californian university community. This study found ST127 to be the second most prevalent strain, increasing from 11 % of all STs identified in isolates collected between 1999 and 2000 to 16 % in 2016-2017 . In light of this recent evidence and reports of emerging resistance to antibiotics, including the cephalosporins, in ST127 isolates [8, [16] [17] [18] , members of this lineage are increasingly becoming a cause for clinical concern and there is potentially a high risk that this clone could emerge as a significant threat to human health. Ongoing surveillance for members of this clone is, therefore, important.
Multi-locus sequence typing (MLST) has been extremely beneficial in the identification of common lineages associated with UTI and BSI. However, because MLST is costly and time consuming it is impractical for the rapid identification of members of the ST127 clone. One solution to these problems is the development of ST-specific PCR assays, as have been designed for other STs [19] [20] [21] ; these have been shown to be very useful in surveillance or in the examination of large culture collections. With the use of comparative genomics and clinical isolates, for the first time we report the design and validation of a three-gene multiplex PCR, incorporating an extraction/PCR control and two ST127 specific targets. The assay is unambiguous in its interpretation and highly specific to E. coli ST127. It is easy to perform and can be used in a clinical setting to rapidly monitor the prevalence and dissemination of this recently emerged, highly virulent clone.
METHODS Strains
A total of 10 ST127 and two ST73 isolates were obtained from the clinical laboratories at Derriford Hospital (University Hospitals Plymouth, UK). Each isolate was recovered from non-duplicate patient urine samples that had been referred to the laboratory for standard microbiological examination for UTI. These ST73 and ST127 isolates were selected for genome sequence analysis from a wider collection of isolates collected between April 2015 and May 2015. The two ST73 isolates were included in the study as they were both isolated in the same urine specimen as one of the ST127 strains. Although this patient was originally identified as having a recurrent monomicrobial UTI, this study identified three individual isolates in the same urine with differing antimicrobial sensitivity patterns (data not shown). Isolates were identified as E. coli by biochemical and MALDI Biotyper analysis (Bruker Daltonics, Inc.). MLST was performed on each of the 12 Derriford isolates using the Achtman scheme [22] (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). In addition to the 12 isolates described above, a total of 131 previously typed UPEC isolates, representing 99 different STs, were obtained from earlier studies, 52 originating from Riyadh, Saudi Arabia [10] , 78 from North West England (including the ST131 reference strain EC958) [1, 23] and the reference ST127 strain 536 [24] .
A total of 29 ST127 isolates were used in the validation of our PCR screening assay. One of these was the well-documented 536 reference isolate and the remainder were clinical isolates from this and our previous studies. Fourteen isolates were confirmed as ST127 by whole-genome sequencing and MLST loci Sanger sequencing, and the remaining 14 ST127 isolates were identified using Sanger sequencing only. Routine cultures of all E. coli used in this study were grown aerobically at 37 C using either lysogeny broth (LB) or LB agar.
Genome sequencing, assembly and annotation of ST127 isolates Draft sequenced genomes were obtained for the 12 specimens isolated from Derriford Hospital (10 ST127 and 2 ST73), two ST127 isolates from Saudi Arabia and two from the North West of England. Sequencing of the E. coli isolates was performed on the Illumia platform by MicrobesNG (https://microbesng.uk/). The genomes were sequenced to a depth of between 48x and 94x coverage, raw sequence data assembled into contigs using SPAdes-3.9.0 25] and the contigs ordered and ligned with reference to the UPEC ST127 536 genome (Accession ref. NC_008253 [26] ) using Mauve 2.4.0 (Darling lab, University of Technology, Sydney). Sequences were concatenated using SeqHandler v0.5 (https://github.com/happykhan/seqhandler) and annotated using prokka 1.11 [27] . Assembly quality was assessed using QUAST 4.0 28] and, as an additional confirmation, genomes were uploaded to the Centre for Genomic Epidemiology MLST website (https://cge.cbs.dtu.dk/services/ MLST) to corroborate the original MLST result. The predicted H antigen serotype of all sequenced ST127 isolates was determined using SerotypeFinder 1.1 29](https://cge. cbs.dtu.dk/services/SerotypeFinder). The complete annotated chromosomes of the sequenced ST127 and ST73 isolates are available at the European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena; accession number ERX2838309).
Comparative genomics
In addition to the UPEC sequence data obtained from the draft genomes listed above, a selection of publicly available genomes were downloaded from the NCBI (National Library of Medicine, Bethesda, MD, USA) database, 
Primer design and PCR protocol
The PCR primer pairs were designed using CLC Genomics Work bench 7.5.1 (https://www.qiagenbioinformatics.com). Primer targets were based on the upaG autotransporter and fliC flagellin gene regions that showed little or no homology in non-ST127 genomes using the NCBI BLAST and UniProt databases. The well-established MLST locus gyrB (DNA gyrase subunit B) primers [22] were incorporated into the multiplex PCR to act as an extraction/PCR control. Primer sequences, concentrations and amplicon size are listed in Table 2 . The DNA template for the PCR reaction was obtained via colony PCR. In brief, a suspension of each isolate was made using material from overnight plate cultures in nuclease-free water (NORMAPUR, BDH Chemicals, VWR) to a turbidity equivalent to a 0.5 McFarland standard. This suspension was diluted 1 : 50, and 1.6 µl used in the final PCR reaction.
Each multiplex PCR reaction was performed using 10 µl of 2Â Biomix Red reaction mix (Bioline, London, UK) in a final PCR volume of 20 µl. A primer concentration of 1 pmol µl À1 , 1.3 pmol µl À1 and 0.85 pmol µl À1 was found to be optimal for each of the upaG, fliC and gyrB primers, respectively, and 0.8 µl of each primer (at the stated concentration) was added to the PCR reaction. PCR was performed on a T100 Thermal cycler (BIO-RAD, Hertfordshire, UK) as follows: an initial denaturation at 98 C for 8 min followed by 36 cycles of 95 C for 30 s, 58 C for 1 min and 72 C for 40 s, with a final extension of 72 C for 5 min. PCR amplification was visualized by running 5 µl of the PCR product on a 1 % agarose gel. Gel images were visualized under UV transillumination, and the number and size of amplicon products determined.
Validation, sensitivity and specificity of ST127-specific PCR To determine the sensitivity and specificity of the assay, a total of 143 strains of E. coli (see strains section) were used to validate the multiplex PCR. The collection consisted of 29 ST127 strains and 114 UPEC isolates representing 98 different STs (Table 3) .
RESULTS AND DISCUSSION
The vast majority of uncomplicated CA-UTIs are treated empirically, leading to significant over-prescription [32] and biasing the collections of isolates investigated in many studies, which include only isolates from clinical microbiology laboratories (i.e. isolates from cases where empirical therapy may have failed). Historically, members of the ST127 clone have been widely susceptible to first-line empirical antibiotics, so will not feature in such culture collections. To gain a better understanding of the true genetic background of UTI aetiological agents, it is paramount that future CA-UTI studies focus on specimens collected from all patients at the point of care prior to empiric treatment. The investigations performed by Yamaji and colleagues [15] go some way to emphasizing the importance of such studies, and being able to rapidly screen for members of ST127 will enable ongoing surveillance in these populations.
Identification of gene regions specific to ST127
Several regions on the ST127 genome were identified as having low homology to genomes of other UPEC STs, using BRIG comparisons (Fig. 1) . Each locus that was identified with 70 % homology underwent further investigation using Blastn and Blastp database comparisons, culminating in the identification of two gene variants highly specific to ST127, namely the fliC gene and a putative upaG gene.
The fliC gene codes for the subunit protein flagellin, the major constituent of the flagellar filament. The flagellin proteins are conserved at terminal regions, while the central region is variable and often carries an H-serotype-specific epitope [33] . This protein is also implicated in pathogen-associated interactions, stimulating the Toll-like 5 receptor [34] which, in turn, has given rise to the prospect of the more conserved regions of the flagellin protein becoming a potent adjuvant in the design of new vaccines for UTI [35, 36] . Each of the sequenced ST127 genomes carried an identical 1668 bp fliC gene, with the single exception being isolate SA189 (from Saudi Arabia), Reverse ATCAGGCCTTCACGCGCATC 0.034 [22] which exhibited a C-to-A substitution at position 699, producing only a synonymous mutation in a valine codon. Using SerotypeFinder 1.1, the ST127 fliC gene was seen to have 100 % identity to the predicted serotype H31 variant, in agreement with previous reports for carriage of this serotype in ST127 strains [37] . The conservation within UPEC ST127 isolates, coupled with the reported variability within the E. coli species and previously published studies employing fliC as a discriminatory marker with enteropathogenic E. coli [38] , justified selection of fliC as a worthy candidate for ST127-specific PCR.
The second locus identified as a putative ST127 marker was a large, 4875 bp gene sequence that shared 73 % identity with the upaG trimeric autotransporter (AT) protein found in E. coli CFT073 [39] . The presumptive UpaG protein sequence in ST127 was found to share many structural features with E. coli CFT073 UpaG, the Yersinia yadA and Haemophilus influenza Hia AT genes, including specific homologies with the Hia and YadA proteins at the C-terminal region and the left-handed beta-roll of YadA at the hydrophobic N-terminal region [40, 41] . The 73 % identity with the CFT073 UpaG is not surprising, because variability within genera and species for the AT family of adhesins is particularly high. The membrane anchor is the only domain that remains homologous throughout the AT and, as such, defines the family [42] . The yadA gene was identified in Yersinia species and originally named P1 [43] , or autoagglutination protein [44] ,and to date remains the best-characterized AT family of adhesins [45, 46] . The AT adhesins are important virulence factors for many Gram-negative pathogens and, although they are universally associated with adherence to epithelial cells and extracellular matrix (ECM) proteins [39] , their functions appear extensive with reported roles in biofilm formation [47] , invasion into host cells [48] and serum resistance [49] . Interpretation of ST127-specific multiplex PCR A positive ST127 isolate was identified by the presence of three distinct DNA bands (Fig. 2) in each of the expected amplicon sizes (Table 2) , and by a negative reaction by the presence of the gyrB band alone or with only one of the two specific targets amplified. Amplification of the gyrB gene was necessary to determine a true negative result.
Specificity and sensitivity of ST127-specific PCR Ideally one PCR target would be used to identify this particular ST but, because of the size and variability within the E. coli pan genome, it was believed that such a precise single PCR target may be over-optimistic. However, the fliC flagellin PCR primers proved to be highly sensitive and specific for the UPEC isolates, producing only three positive results in non-ST127 isolates -ST372, ST420 and ST1529. The fliC primers alone produced a sensitivity and specificity of 100 and 97.3 %, respectively. This suggests that the H31 serotype is less common amongst other UPEC strains and, although not exclusive to ST127, remains relatively specific. It is possible that our PCR may fail to identify less common ST127 that do not possess the H31 fliC gene although, to the best of our knowledge, no such strains have been identified to date. The three non-ST127 STs that were positive for the fliC primers were not closely related to the ST127 clone, as ST372 contained only three of the seven matching ST127 MLST alleles (gyrB, icd and mdh), ST420 contained only one matching allele (adk) and ST1529 contained no matching alleles. The upaG primers alone were less specific (92.1 %), with nine non-ST127 isolates (ST14, ST80, ST141, ST537, ST540, ST550, ST785, ST807 and ST998) producing an amplicon from the upaG primers. Three of the upaGpositive results in non-ST127 strains (ST14, ST550 and ST807) produced a shortened amplicon in the range 900-1100 bp (Fig. 3) . Of the non-ST127 isolates that recorded a positive result with the UpaG primers, none were particularly closely related to ST127. ST80 had four matching MLST alleles (adk, gyrB, mdh and recA), ST537 three matching alleles (fumC, purA and recA) and the remaining STs had only two or fewer matching alleles.
The two primers used in combination gave 100 % sensitivity and specificity when tested against the 143 isolates, representing strains from 99 diverse UPEC-associated STs. The assay was optimized with and without the inclusion of the gyrB extraction/PCR control and using both purified DNA (data not shown) and colony PCR. On rare occasion when a weak upaG and/or fliC amplicon was observed during validation, PCR was retested with both the three-locus multiplex PCR and the gyrB primers removed from the reaction. The removal of the competing gyrB primers from the multiplex PCR can increase the concentration of ST127-specific target amplicons, thus enhancing visualization of ST127-specific bands.
Although a PCR assay targeting a hypothetical protein for the detection of ST127 has been published by Ciesielczuk et al. [2] in 2016, their study did not provide any clinical validation. Their PCR used a single locus to identify ST127 and, while our own in silico analysis predicts that their primers should have high specificity, with no laboratory validation of performance the utility of this assay has not been confirmed. The three false-positive results we found with our primers for fliC indicate that even primers which appear highly specific in silico may perform less well when used in practice. From a total of the 275 ST127 genomes/isolates analysed in this study, 259 contained the O6 antigen while the O antigen was absent in 14, and only two isolates contained an O antigen at variance with the norm (antigens O15 and O75). When these results are seen in comparison to the study performed by Ciesielczuk and colleagues, who found five different O serotypes in just 28 isolates, the importance of validation for the detection of falsepositive and -negative results is emphasized. A significant finding of our study was that no single primer pair was able reliably to identify ST127 and, to achieve this, a combination of PCR targets was required. Additionally, any specific PCR assay without the presence of an extraction/PCR control will always introduce an element of doubt upon obtaining a negative result. This will reduce the practicality for use in a diagnostic setting. Although our multiplex PCR approach successfully identified all ST127s from a large collection of UPEC STs, and from very different locations in the UK and Saudi Arabia, further confirmation of performance using isolates from other geographical locations would be of value.
Concluding remarks
It is understood that the presence of antimicrobial resistance in a pathogen is a prerequisite for increased prevalence; however, in the case of extra-intestinal pathogenic E. coli (ExPEC), resistance may not be the dominant driver towards increased prevalence. Recent studies show that drug-resistant and -susceptible strains have both remained equally prevalent in UTI and BSI over the last 17 and 11 years, respectively [15, 50] . Furthermore, in the case of the globally disseminated ST131 clone, acquisition of specific virulence determinants predates the mutations in the gyrA and parC genes that led to the development of fluoroquinolone resistance in Clade C2 strains carrying the CTX-M-15 ESBL gene [51] . This suggests that the presence or acquisition of virulence genes in ExPEC may be the necessary precursor for the future success of a pathogen. The high virulence potential of ST127 is of clinical concern, and evidence for the increase in CA-UTI warrants increased surveillance for members of this ST.
Here, we report the first validated multiplex PCR for detection of ST127 E. coli. The assay is simple yet highly discriminatory, rapid, robust, reliable and inexpensive. Multiplex PCR can also be performed directly from individual colonies, removing the need for any extraction or DNA purification protocols. We suggest that such assays have a central role in surveillance for key UPEC clones. We urge laboratories to increase surveillance for ST127 isolates, on a prospective basis, to reduce the potential impact of isolates from this virulent clone that is increasingly being shown to acquire resistance.
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